Insiders · PAND

Eric D Larson

Officer at Pandion Therapeutics, Inc. (PAND)

Eric D Larson has filed 2 insider reports with the SEC since February 2021, as officer at Pandion Therapeutics, Inc. (PAND). The latest filing, on April 1, 2021, reports sale back to the company and tender of shares in a change of control at Pandion Therapeutics, Inc. (PAND).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Eric D Larson is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pandion Therapeutics, Inc. logo
PAND
Pandion Therapeutics, Inc.
Officer0Apr 1, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric D Larson with

Questions about Eric D Larson

What is Eric D Larson's role at Pandion Therapeutics, Inc.?
Eric D Larson reports to the SEC as officer at Pandion Therapeutics, Inc. (PAND), according to the latest filing on April 1, 2021.
Has Eric D Larson bought or sold stock recently?
No open-market purchases or sales by Eric D Larson are on file. The filings report sale back to the company, tender of shares in a change of control and grant or award.
How do I get alerts when Eric D Larson files?
Follow Eric D Larson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric D Larson (SEC CIK 0001688239). Totals count each trade once, skipping amendments whose original is on file, from Feb 10, 2021 on. View on SEC EDGAR · Get this as JSON